U.S., Oct. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07206160) titled 'Effect of Dapagliflozin on Interleukin 10 in Sepsis' on Sept. 25.
Brief Summary: The goal of this observational study is to learn about the long-term effects of dapagliflozin as anti-inflammatory agents to improve organ dysfunction and decrease mortality on patients of both genders ageing 18 years or above with sepsis.
1ry Outcome: The anti-inflammatory effect of dapagliflozin in patients with sepsis evaluated by: Effect on inflammatory markers (IL-10).
2ry Outcomes:
1. Severity of sepsis evaluated by the SOFA score.
2. Prognostic value of HDL compared to IL-10 for multi organ failure and death in septic patients and their correl...